Medtronic plc (0Y6X.L)
USD 82.7
(0.68%)
USD 82.7
(0.68%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 24.96 Billion USD | 2.49% |
| 2022 | 25.41 Billion USD | 1.72% |
| 2021 | 24.98 Billion USD | -8.83% |
| 2020 | 27.4 Billion USD | 6.46% |
| 2019 | 25.74 Billion USD | 1.65% |
| 2018 | 25.32 Billion USD | -1.68% |
| 2017 | 25.75 Billion USD | -22.98% |
| 2016 | 33.44 Billion USD | 7.52% |
| 2015 | 31.1 Billion USD | -14.18% |
| 2014 | 36.24 Billion USD | 203.91% |
| 2013 | 11.92 Billion USD | 11.92% |
| 2012 | 10.65 Billion USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 27.81 Billion USD | 6.98% |
| 2023 Q4 | 26.04 Billion USD | 3.43% |
| 2023 FY | 26.04 Billion USD | 2.49% |
| 2023 Q1 | 24.98 Billion USD | -1.7% |
| 2023 Q3 | 25.18 Billion USD | 0.41% |
| 2023 Q2 | 25.08 Billion USD | 0.39% |
| 2022 Q3 | 28.12 Billion USD | 5.68% |
| 2022 Q1 | 23.21 Billion USD | -7.1% |
| 2022 FY | 25.41 Billion USD | 1.72% |
| 2022 Q4 | 25.41 Billion USD | -9.65% |
| 2022 Q2 | 26.61 Billion USD | 14.68% |
| 2021 Q1 | 25.96 Billion USD | -5.25% |
| 2021 Q3 | 25.15 Billion USD | -1.83% |
| 2021 Q4 | 24.98 Billion USD | -0.68% |
| 2021 Q2 | 25.62 Billion USD | -1.31% |
| 2021 FY | 24.98 Billion USD | -8.83% |
| 2020 Q1 | 28.69 Billion USD | 12.22% |
| 2020 FY | 27.4 Billion USD | 6.46% |
| 2020 Q2 | 30 Billion USD | 4.59% |
| 2020 Q3 | 30.32 Billion USD | 1.05% |
| 2020 Q4 | 27.4 Billion USD | -9.63% |
| 2019 FY | 25.74 Billion USD | 1.65% |
| 2019 Q3 | 26.42 Billion USD | -0.13% |
| 2019 Q2 | 26.46 Billion USD | -2.2% |
| 2019 Q1 | 27.05 Billion USD | 6.87% |
| 2019 Q4 | 25.56 Billion USD | -3.26% |
| 2018 Q3 | 25.04 Billion USD | 0.02% |
| 2018 Q2 | 25.03 Billion USD | -0.82% |
| 2018 Q1 | 25.24 Billion USD | -2.05% |
| 2018 FY | 25.32 Billion USD | -1.68% |
| 2018 Q4 | 25.31 Billion USD | 1.11% |
| 2017 Q1 | 34.02 Billion USD | 1.72% |
| 2017 Q3 | 28.83 Billion USD | -0.85% |
| 2017 Q4 | 25.77 Billion USD | -10.62% |
| 2017 FY | 25.75 Billion USD | -22.98% |
| 2017 Q2 | 29.08 Billion USD | -14.52% |
| 2016 Q3 | 32.18 Billion USD | -0.79% |
| 2016 FY | 33.44 Billion USD | 7.52% |
| 2016 Q2 | 32.44 Billion USD | 0.9% |
| 2016 Q4 | 33.44 Billion USD | 3.92% |
| 2016 Q1 | 32.15 Billion USD | 3.56% |
| 2015 FY | 31.1 Billion USD | -14.18% |
| 2015 Q4 | 31.04 Billion USD | -13.47% |
| 2015 Q3 | 35.88 Billion USD | -0.12% |
| 2015 Q2 | 35.92 Billion USD | 0.91% |
| 2015 Q1 | 35.6 Billion USD | -1.77% |
| 2014 FY | 36.24 Billion USD | 203.91% |
| 2014 Q3 | 28.89 Billion USD | 110.82% |
| 2014 Q2 | 13.7 Billion USD | 7.09% |
| 2014 Q1 | 12.8 Billion USD | 7.34% |
| 2014 Q4 | 36.24 Billion USD | 25.41% |
| 2013 Q1 | 11.19 Billion USD | 5.07% |
| 2013 Q3 | 12.23 Billion USD | -0.45% |
| 2013 FY | 11.92 Billion USD | 11.92% |
| 2013 Q4 | 11.92 Billion USD | -2.52% |
| 2013 Q2 | 12.28 Billion USD | 9.76% |
| 2012 Q3 | - USD | 0.0% |
| 2012 FY | 10.65 Billion USD | 0.0% |
| 2012 Q4 | 10.65 Billion USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Phreesia, Inc. | 11.98 Million USD | -208220.12% |
| Accuray Incorporated | 172.15 Million USD | -14400.221% |
| Align Technology, Inc. | 96.96 Million USD | -25643.544% |
| Elevance Health Inc. | 25.12 Billion USD | 0.625% |
| AxoGen, Inc. | 69.29 Million USD | -35925.804% |
| Boston Scientific Corporation | 9.09 Billion USD | -174.409% |
| CVS Health Corporation | 79.38 Billion USD | 68.555% |
| Cardinal Health, Inc. | 5.6 Billion USD | -345.053% |
| Centene Corporation | 17.69 Billion USD | -41.042% |
| DaVita Inc. | 11.11 Billion USD | -124.56% |
| HCA Healthcare, Inc. | 41.85 Billion USD | 40.364% |
| Hologic, Inc. | 2.53 Billion USD | -884.889% |
| Humana Inc. | 10.21 Billion USD | -144.424% |
| IDEXX Laboratories, Inc. | 947.88 Million USD | -2533.561% |
| Laboratory Corporation of America Holdings | 5.95 Billion USD | -319.25% |
| Masimo Corporation | 970 Million USD | -2473.505% |
| McKesson Corporation | 5.47 Billion USD | -356.195% |
| Patterson Companies, Inc. | 762.94 Million USD | -3171.948% |
| Quest Diagnostics Incorporated | 5.36 Billion USD | -364.947% |
| ResMed Inc. | 873.93 Million USD | -2756.391% |
| Henry Schein, Inc. | 2.74 Billion USD | -810.726% |
| Teladoc Health, Inc. | 1.59 Billion USD | -1467.755% |
| Universal Health Services, Inc. | 5.36 Billion USD | -365.152% |
| Veeva Systems Inc. | 55.77 Million USD | -44656.611% |
| Baxter International Inc. | 14.36 Billion USD | -73.789% |
| Becton, Dickinson and Company | 15.87 Billion USD | -57.208% |
| Intuitive Surgical, Inc. | 89.8 Million USD | -27698.441% |
| Danaher Corporation | 19.35 Billion USD | -28.968% |
| Stryker Corporation | 12.99 Billion USD | -92.097% |